U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07446166) titled 'TETANUS Antibody Detection in Saliva Study' on Feb. 18.
Brief Summary: This study aims to design, develop and optimise a non-invasive, saliva sample-based point-of-care lateral flow test for use in low and middle income settings that can return a qualitative result on whether an individual has or has not immunity to tetanus within 10-15mins. If successful, this approach would not require blood sampling or laboratory facilities, empower personalised decision making on vaccine needs and support the development of population level data-driven public health policies.
Study Start Date: Feb. 01
Study Type: INTERVENTIONAL
Condition:
Te...